OpenAI has posted a job listing offering nearly half a million annually for a safety researcher tasked with considering risks ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs ...

Richard Socher, known for founding chatbot startup You.com and for earlier work tied to ImageNet, has launched a new AI startup called Recursive Superintelligence, or RSI, with $650 million in funding ...

A new frontier AI company called Recursive Superintelligence has emerged from stealth with $650 million in funding and an ...

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...

Ex-Meta and DeepMind researchers raised $650m at a $4.65bn valuation for Recursive Superintelligence, a startup betting AI can automate its own research.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

ABSTRACT: Automatic detection of cognitive distortions from short written text could support large-scale mental-health screening and digital cognitive-behavioural therapy (CBT). Many recent approaches ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

One reason Recursion Pharmaceuticals could become a big deal is that its goal is to usher a paradigm shift into the pharmaceutical industry. Even with impressive technological progress over the past ...